Not applicableUnknownNCT05760391What this trial is testingIO Plus Radiotherapy in Patients With Advanced ESCC.Who this might be right forMetastatic Esophageal Squamous Cell Carcinoma Fudan University 100
Large-scale testing (Phase 3)Study completedNCT00410761What this trial is testingAn Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid CancerWho this might be right forThyroid Cancer Genzyme, a Sanofi Company 331
Large-scale testing (Phase 3)Study completedNCT00704730What this trial is testingEfficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid CancerWho this might be right forThyroid Cancer Exelixis 330
Testing effectiveness (Phase 2)Active Not RecruitingNCT03485209What this trial is testingEfficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsWho this might be right forColorectal NeoplasmsCarcinoma, Non-Small-Cell LungExocrine Pancreatic Cancer+1 more Seagen, a wholly owned subsidiary of Pfizer 350
Early research (Phase 1)Looking for participantsNCT06778863What this trial is testingCLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationWho this might be right forAdvanced Solid TumorUnresectable Solid TumorMetastatic Solid Tumor+8 more Clasp Therapeutics, Inc. 90
Testing effectiveness (Phase 2)Study completedNCT01178944What this trial is testingPralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionEsophageal Undifferentiated CarcinomaGastric Adenocarcinoma+14 more Roswell Park Cancer Institute 35
Testing effectiveness (Phase 2)Looking for participantsNCT06682793What this trial is testingEvaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 ExpressionWho this might be right forSolid Tumor, AdultColorectal CancerNon-Small Cell Lung+14 more A2 Biotherapeutics Inc. 240
Early research (Phase 1)Study completedNCT03821233What this trial is testingA Dose Finding Study of ZW49 in Patients With HER2-Positive CancersWho this might be right forHER2-expressing Cancers Zymeworks BC Inc. 112
Early research (Phase 1)Looking for participantsNCT07114601What this trial is testingLY4257496 in Participants With Cancer (OMNIRAY)Who this might be right forBreast NeoplasmsColorectal NeoplasmsProstate Neoplasm+4 more Eli Lilly and Company 421
Early research (Phase 1)Study completedNCT04641871What this trial is testingSym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor MalignanciesWho this might be right forMetastatic CancerSolid Tumor Symphogen A/S 78
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06713057What this trial is testingEfficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid CancerWho this might be right forLocally Advanced Thyroid Gland CarcinomaThyroid Cancer West China Hospital 20
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Ended earlyNCT00126607What this trial is testingTrastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland CancerWho this might be right forHigh-grade Salivary Gland Mucoepidermoid CarcinomaRecurrent Salivary Gland CancerSalivary Gland Acinic Cell Tumor+5 more National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT05081609What this trial is testingInvestigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor MalignanciesWho this might be right forAdvanced Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor+10 more Ascendis Pharma Oncology Division A/S 320
Not applicableActive Not RecruitingNCT05812027What this trial is testingA Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid TumorsWho this might be right forHead and Neck CancerCervical CancerNon Small Cell Lung Cancer+4 more TScan Therapeutics, Inc. 1,150
Not applicableStudy completedNCT00388024What this trial is testingPET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation TherapyWho this might be right forCarcinoma of Unknown PrimaryHead and Neck Cancer Wake Forest University Health Sciences 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07688291What this trial is testingA Phase II Study of PD-1/IL-2α-bias Bispecific Antibody Fusion Protein Monotherapy in Advanced Esophageal Squamous Cell Carcinoma After Failure of Prior ICI Plus Platinum-Based ChemotherapyWho this might be right forEsophageal Squamous Carcinoma Cell Beijing GoBroad Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT00782041What this trial is testingPatients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical CancerWho this might be right forUterine Neoplasms Sanofi 11
Testing effectiveness (Phase 2)Ended earlyNCT03233724What this trial is testingOral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal CarcinomasWho this might be right forCarcinoma, Non-Small-Cell LungLung CancerNon-Small Cell Lung Cancer+2 more National Cancer Institute (NCI) 9
Not applicableStudy completedNCT00068497What this trial is testingGefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung CancerWho this might be right forAnaplastic Thyroid CancerInsular Thyroid CancerMetastatic Parathyroid Cancer+83 more National Cancer Institute (NCI) 40